Cargando…

Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis

Alterations from the normal set of chromosomes are extremely common as cells progress toward tumourigenesis. Similarly, we expect to see disruption of normal cellular metabolism, particularly in the use of glucose. In this review, we discuss the connections between these two processes: how chromosom...

Descripción completa

Detalles Bibliográficos
Autores principales: Newman, David L., Gregory, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770258/
https://www.ncbi.nlm.nih.gov/pubmed/31540349
http://dx.doi.org/10.3390/ijms20184611
_version_ 1783455429825658880
author Newman, David L.
Gregory, Stephen L.
author_facet Newman, David L.
Gregory, Stephen L.
author_sort Newman, David L.
collection PubMed
description Alterations from the normal set of chromosomes are extremely common as cells progress toward tumourigenesis. Similarly, we expect to see disruption of normal cellular metabolism, particularly in the use of glucose. In this review, we discuss the connections between these two processes: how chromosomal aberrations lead to metabolic disruption, and vice versa. Both processes typically result in the production of elevated levels of reactive oxygen species, so we particularly focus on their role in mediating oncogenic changes.
format Online
Article
Text
id pubmed-6770258
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67702582019-10-30 Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis Newman, David L. Gregory, Stephen L. Int J Mol Sci Review Alterations from the normal set of chromosomes are extremely common as cells progress toward tumourigenesis. Similarly, we expect to see disruption of normal cellular metabolism, particularly in the use of glucose. In this review, we discuss the connections between these two processes: how chromosomal aberrations lead to metabolic disruption, and vice versa. Both processes typically result in the production of elevated levels of reactive oxygen species, so we particularly focus on their role in mediating oncogenic changes. MDPI 2019-09-18 /pmc/articles/PMC6770258/ /pubmed/31540349 http://dx.doi.org/10.3390/ijms20184611 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Newman, David L.
Gregory, Stephen L.
Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis
title Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis
title_full Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis
title_fullStr Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis
title_full_unstemmed Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis
title_short Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis
title_sort co-operation between aneuploidy and metabolic changes in driving tumorigenesis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770258/
https://www.ncbi.nlm.nih.gov/pubmed/31540349
http://dx.doi.org/10.3390/ijms20184611
work_keys_str_mv AT newmandavidl cooperationbetweenaneuploidyandmetabolicchangesindrivingtumorigenesis
AT gregorystephenl cooperationbetweenaneuploidyandmetabolicchangesindrivingtumorigenesis